Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 24,700 shares at $11.52 ($282K) on 2007-11-26, disclosed to the SEC on 2007-11-27.
Scheduled sale ($282k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.23 | 300 | $3K | 1.2% |
| 2 | $11.24 | 400 | $4K | 1.6% |
| 3 | $11.25 | 1,300 | $15K | 5.2% |
| 4 | $11.26 | 600 | $7K | 2.4% |
| 5 | $11.27 | 600 | $7K | 2.4% |
| 6 | $11.28 | 1,500 |
| $17K |
| 6.0% |
| 7 | $11.29 | 300 | $3K | 1.2% |
| 8 | $11.30 | 300 | $3K | 1.2% |
| 9 | $11.31 | 600 | $7K | 2.4% |
| 10 | $11.32 | 600 | $7K | 2.4% |
| 11 | $11.33 | 300 | $3K | 1.2% |
| 12 | $11.35 | 300 | $3K | 1.2% |
| 13 | $11.37 | 900 | $10K | 3.6% |
| 14 | $11.38 | 1,200 | $14K | 4.8% |
| 15 | $11.39 | 1,000 | $11K | 4.0% |
| 16 | $11.40 | 600 | $7K | 2.4% |
| 17 | $11.41 | 600 | $7K | 2.4% |
| 18 | $11.42 | 700 | $8K | 2.8% |
| 19 | $11.43 | 900 | $10K | 3.7% |
| 20 | $11.44 | 1,000 | $11K | 4.1% |
| 21 | $11.45 | 1,800 | $21K | 7.3% |
| 22 | $11.46 | 1,158 | $13K | 4.7% |
| 23 | $11.47 | 1,642 | $19K | 6.7% |
| 24 | $11.48 | 1,200 | $14K | 4.9% |
| 25 | $11.49 | 1,200 | $14K | 4.9% |
| 26 | $11.50 | 600 | $7K | 2.4% |
| 27 | $11.51 | 400 | $5K | 1.6% |
| 28 | $11.52 | 900 | $10K | 3.7% |
| 29 | $11.53 | 600 | $7K | 2.5% |
| 30 | $11.54 | 1,200 | $14K | 4.9% |
| Total | $11.40 avg | 24,700 | $282K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |